← All trials
NCT04901988
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 8, 2021
- Primary completion
- Oct 1, 2030
- Completion date
- Oct 1, 2030
- First posted
- May 26, 2021
- Last posted
- Nov 18, 2021
- Enrollment
- 1050
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Christie NHS Foundation TrustLead sponsor
- The Christie NHS Foundation TrustOverall official - principal investigator
- University of ManchesterCollaborator
- University of ManchesterCollaborator
- University of LiverpoolCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.